Martine A Rothblatt sold $3.9M of UTHR
Chairperson & CEO at UNITED THERAPEUTICS Corp. 7,580 shares at an average of $517.97, traded Sep 30, 2026, filed Oct 1, 2026.
Score components
- +25RoleCEO
- +25Trade size$3.9M at market
- 0Share of holdings soldSold 2.3% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001106578-26-000153, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | MOption exercise Common Stockindirect: by Trust10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -161 | $476.14 | $77k | 333,782 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -749 | $477.43 | $358k | 333,033 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -650 | $478.47 | $311k | 332,383 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -359 | $479.67 | $172k | 332,024 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -601 | $480.79 | $289k | 331,423 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -160 | $482.36 | $77k | 331,263 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -80 | $487.79 | $39k | 331,183 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -40 | $495.32 | $20k | 331,143 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -40 | $511.37 | $20k | 331,103 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -80 | $514.90 | $41k | 331,023 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -80 | $517.17 | $41k | 330,943 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -80 | $523.36 | $42k | 330,863 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -80 | $524.62 | $42k | 330,783 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -80 | $526.09 | $42k | 330,703 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -160 | $531.11 | $85k | 330,543 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -160 | $536.52 | $86k | 330,383 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -200 | $537.67 | $108k | 330,183 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -40 | $538.65 | $22k | 330,143 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -480 | $540.78 | $260k | 329,663 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -580 | $541.76 | $314k | 329,083 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -600 | $543.25 | $326k | 328,483 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -840 | $544.05 | $457k | 327,643 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -920 | $545.13 | $502k | 326,723 | 10 d ago |
| Sep 30, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -360 | $546.23 | $197k | 326,363 | 10 d ago |
| Sep 30, 2026 | MOption exercise Stock Optionderivativeindirect: by Trust10b5-1 | -9,500 | $0.00 | $0 | 328,410 | 10 d ago |
Related signals
Other insiders at UNITED THERAPEUTICS Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.2M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.2M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.5M 9,500 shares | -3% | |
| 18Weak | UNITED THERAPEUTICS Corp | Paul A Mahon EVP & GENERAL COUNSEL | $4.7M 8,300 shares | -16% | |
| 38Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $1.1M 1,920 shares | -1% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $4.5M 9,500 shares | -3% | |
| 30Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $4.6M 9,500 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.